ACE inhibitor-induced bronchial reactivity in patients with respiratory dysfunction

Annals of Pharmacotherapy

Volumn 36, Issue 6, 2002, Pages 1058-1067

  Packard, Kathleen A ^a   Wurdeman, Richard L ^a   Arouni, Amy J ^a  

^a CREIGHTON UNIVERSITY CARDIAC CENTER   (United States)

Author keywords

Angiotensin II receptor antagonists; Angiotensin converting enzyme inhibitors; Asthma; Bronchospasm; Chronic obstructive pulmonary disease; Congestive heart failure; Cough

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BEZAFIBRATE; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; HYDRALAZINE; ISOSORBIDE DINITRATE; LISINOPRIL; LOSARTAN; METOLAZONE; NIFEDIPINE; RAMIPRIL; SPIRAPRIL; VASODILATOR AGENT; VERAPAMIL; ANGIOTENSIN RECEPTOR;

ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COUGHING; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG RESPONSE; HUMAN; HYPERTENSION; INCIDENCE; MEDICAL LITERATURE; PRIORITY JOURNAL; PUBLICATION; RESPIRATORY TRACT DISEASE; RISK FACTOR; BRONCHUS DISEASE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; META ANALYSIS; METABOLISM; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASTHMA; BRONCHIAL DISEASES; CLINICAL TRIALS; HEART FAILURE, CONGESTIVE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0036014078     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A332     Document Type: Article

References (72)

1. Adverse effects profile of sulfhydryl compounds in man
2. ACE-inhibitor-induced cough, an adverse drug reaction unrecognized for several years: Studies in prescription-event monitoring
3. Acute and chronic effects of angiotensin-converting enzyme inhibitor captopril in severe hypertension
4. Safety profiles of the angiotensin converting enzyme inhibitors captopril and enalapril
5. Cough associated with captopril and enalapril
6. Prevalence of cough during angiotensin-converting enzyme inhibitor therapy
7. Cough and ACE inhibitors
8. Effect of angiotensin-converting enzyme inhibition on bronchial responsiveness
9. The comparative effects of angiotensin and noradrenaline on consecutive vascular sections
10. Interaction between sympathetic and renin-angiotensin system
11. The effects of intravenous infusions of valine-5 angiotensin II and other pressor agents on urinary electrolytes and corticoids including aldosterone
12. Effects of angiotensin II on arginine-vasopressin in physiological and pathological situations in man
13. Pharmacology of bradykinin and related kinins
14. Endothelium and control of vascular function: State of the art lecture
15. The effect of bradykinin on proximal tubular sodium reabsorption in the dog: Evidence for functional nephron heterogeneity
16. Kinin formation: Mechanisms and role in inflammatory disorders
17. Biochemistry of angiotensin I-converting enzyme
18. Angiotensin converting enzyme inhibition in tissues from spontaneously hypertensive rats after treatment with captopril or MK-421
19. Bradykinin-induced bronchoconstriction in humans
20. Effect of inhalations of bradykinin on healthy and atopic (asthmatic) children
21. Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme
22. Inhaled sodium cromoglycate in angiotensin-converting enzyme inhibitor cough
23. Pathophysiology and clinical presentations of cough
24. Angiotensin-converting enzyme inhibition and prostaglandins
25. Neurophysiology of the cough reflex
26. Thromboxane antagonism and cough induced by angiotensin- converting-enzyme inhibitor
27. 2 synthetase inhibition suppresses cough induced by angiotensin converting enzyme inhibitors
28. Effects of sulindac on angiotensin converting enzyme inhibitor-induced cough: Randomized placebo-controlled double-blind cross-over study
29. Effects of nifedipine and indomethacin on cough induced by angiotensin-converting enzyme inhibitors: A double-blind, randomized, cross-over study
30. The positive association of cough with angiotensin-converting enzyme inhibitors
31. GABA-B receptor modulation of the release of substance P from capsaicin-sensitive neurons in the rat trachea in vitro
32. Inhibition of bronchial hyperresponsiveness by the GABA-agonist baclofen
33. Use of baclofen to suppress cough induced by angiotensin-converting enzyme inhibitors
34. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology
35. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists; the design of a prospective controlled study
36. Release of histamine from mast cells by vasoactive peptides
37. Cough and other bronchial symptoms and skin disorders during treatment with ACE inhibitors
38. Cough and wheeze caused by inhibitors of angiotensin-converting enzyme
39. Bronchial hyperreactivity in patients who cough after receiving angiotensin converting enzyme inhibitors
40. Bronchial hyperreactivity and cough induced by angiotensin-converting enzyme-inhibitor therapy
41. Bronchial hyperreactivity induced by angiotensin converting enzyme inhibitor
42. Captopril-related (and induced?) asthma
43. Increased cough reflex associated with angiotensin-converting enzyme inhibitor cough
44. Silencing chronic cough
45. Captopril and bronchial reactivity
46. Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium channel blocker on blood pressure and respiratory function in patients with hypertension and asthma
47. Effects of captopril on blood pressure and respiratory function compared to verapamil in patients with hypertension and asthma
48. Angiotensin-converting enzyme inhibitors in patients with bronchial responsiveness and asthma
49. Bronchial responses to enalapril in asthmatic, hypertensive patients
50. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors
51. The effect of an angiotensin converting enzyme inhibitor, ramipril, on bronchial responses to inhaled histamine and bradykinin in asthmatic subjects
52. Bronchospasm and cough as adverse reactions to the ACE-inhibitors captopril, enalapril, and lisinopril. A controlled retrospective cohort study
53. Comparisons of long-term effects of lisinopril versus nifedipine versus conventional therapy in the treatment of mild to moderate hypertension in patients with chronic obstructive pulmonary disease
54. Influence of ACE inhibition on pulmonary haemodynamics and function in patients in whom beta-blockers are contraindicated
55. The effects of enalapril on exercise capacity and right ventricular function in patients with chronic cor pulmonale
56. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure
57. Angiotensin-converting enzyme inhibitors and cough: A prospective evaluation in hypertension and in congestive heart failure
58. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
59. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
60. Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) Registry
61. Decrease by ACE-inhibition of the excessive alveolar-capillary membrane resistance to gas transfer in chronic heart failure
62. Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: Correlation with physical performance
63. Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin
64. Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy
65. Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure
66. Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril) on ventilation during exercise in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy
67. Angiotensin- converting enzyme inhibition facilitates alveolar capillary gas transfer and improves ventilation-perfusion coupling in patients with left ventricular dysfunction
68. Angiotensin-converting enzyme inhibitor therapy improves respiratory muscle strength in patients with heart failure
69. Losartan-induced bronchospasm
70. Double-blind comparison of losartan, lisinopril and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough
71. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensinconverting enzyme inhibitors
72. Effect of angiotensin II receptor blockade on bronchial responsiveness in asthmatic subjects